
Biogen BIIB
$ 199.76
0.2%
Quarterly report 2026-Q1
added 04-29-2026
Biogen PEG Ratio 2011-2026 | BIIB
Annual PEG Ratio Biogen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.62 | -1.57 | -1.63 | -1.84 | -2.7 | -1.6 | 0.194 | 0.187 | -0.997 | 1.58 | 0.745 | 0.54 | 1.14 | 1.92 | 0.821 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.92 | -2.7 | -0.106 |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
0.0115 | - | 5743.5 % | $ 69.7 M | ||
|
MorphoSys AG
MOR
|
-0.169 | - | 2.43 % | $ 254 M | ||
|
Happiness Biotech Group Limited
HAPP
|
-0.156 | - | 1.35 % | $ 17.8 M | ||
|
AgeX Therapeutics
AGE
|
-0.51 | - | -10.17 % | $ 12.2 K | ||
|
Arcturus Therapeutics Holdings
ARCT
|
0.0261 | $ 8.45 | 2.36 % | $ 231 M | ||
|
Coherus BioSciences
CHRS
|
-0.0207 | $ 1.76 | 2.87 % | $ 206 M | ||
|
I-Mab
IMAB
|
-0.75 | - | - | $ 866 M | ||
|
Midatech Pharma plc
MTP
|
-0.0114 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
-0.747 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
-0.0281 | - | 2.54 % | $ 160 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
0.254 | - | -1.52 % | $ 24.7 M | ||
|
Athira Pharma
ATHA
|
0.0276 | - | - | $ 269 M | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
-0.232 | $ 0.75 | 0.09 % | $ 34.3 M | ||
|
BiondVax Pharmaceuticals Ltd.
BVXV
|
1.57 | - | 0.74 % | $ 768 M | ||
|
Esperion Therapeutics
ESPR
|
0.799 | $ 3.13 | - | $ 651 M | ||
|
Exelixis
EXEL
|
-2.14 | $ 50.01 | 1.11 % | $ 13.6 B | ||
|
Fortress Biotech
FBIO
|
0.044 | $ 2.19 | -2.88 % | $ 61.1 M | ||
|
Forte Biosciences
FBRX
|
-0.00934 | $ 24.59 | 1.24 % | $ 318 M | ||
|
AbCellera Biologics
ABCL
|
0.17 | $ 4.81 | -2.83 % | $ 1.44 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
0.154 | $ 18.1 | 3.43 % | $ 846 M | ||
|
BioNTech SE
BNTX
|
0.00586 | $ 92.75 | -0.97 % | $ 22.4 B | ||
|
Compugen Ltd.
CGEN
|
0.0951 | $ 2.84 | 0.35 % | $ 265 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-2.8 | - | - | - | ||
|
Checkmate Pharmaceuticals
CMPI
|
0.189 | - | - | $ 231 M | ||
|
Genmab A/S
GMAB
|
0.277 | $ 26.57 | -1.94 % | $ 1.72 B | ||
|
Advaxis
ADXS
|
-0.000022 | - | -9.65 % | $ 45.9 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.000013 | $ 3.53 | 4.26 % | $ 5.81 M | ||
|
Aeterna Zentaris
AEZS
|
0.00152 | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-0.0134 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
4.05 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.00894 | - | - | $ 26.5 M | ||
|
Grifols, S.A.
GRFS
|
-0.048 | $ 7.65 | 1.2 % | $ 5.2 B | ||
|
AIkido Pharma
AIKI
|
-0.000778 | - | 1.93 % | $ 17.4 M | ||
|
Fennec Pharmaceuticals
FENC
|
0.178 | $ 6.87 | -2.28 % | $ 196 M | ||
|
Akero Therapeutics
AKRO
|
-0.964 | - | - | $ 3.67 B | ||
|
Aptose Biosciences
APTO
|
-0.000164 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
-0.0809 | - | -39.0 % | $ 4.57 M | ||
|
Akouos
AKUS
|
0.105 | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
-2.41 | - | -0.23 % | $ 916 M | ||
|
AlloVir
ALVR
|
0.1 | - | 4.14 % | $ 49.1 M | ||
|
Allakos
ALLK
|
0.664 | - | - | $ 28.6 M | ||
|
Arcutis Biotherapeutics
ARQT
|
6.77 | $ 21.43 | 3.58 % | $ 2.73 B | ||
|
Allena Pharmaceuticals
ALNA
|
-0.0713 | - | 3.16 % | $ 1.9 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-0.000293 | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
0.133 | - | - | $ 10.1 M | ||
|
Galectin Therapeutics
GALT
|
0.235 | $ 2.27 | 0.67 % | $ 145 M | ||
|
Alpine Immune Sciences
ALPN
|
4.18 | - | - | $ 2.17 B | ||
|
Aileron Therapeutics
ALRN
|
-0.00319 | - | 10.36 % | $ 9.8 M | ||
|
Applied Therapeutics
APLT
|
0.243 | - | - | $ 8.42 M |